Form 4: IN8BIO Director Brandt Amends Warrants and Acquires Shares
SEC Form 4 Filing
Director Peter C. Brandt reports changes in beneficial ownership of IN8BIO, Inc. securities, including warrant amendments and share acquisitions.
Summary
- Peter C. Brandt, a director of IN8BIO, Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
- On October 4, 2024, Brandt acquired 253,164 shares of common stock as part of a unit purchase at $0.395 per unit, with each unit including one share and one Series C warrant.
- He also amended existing Series A warrants, effectively cancelling the old warrants with a $1.25 exercise price and June 13, 2025 expiration, and replacing them with new warrants at a $0.45 exercise price expiring on October 4, 2025.
- Additionally, Brandt acquired 81,967 Series A warrants at $0.45.
- Following these transactions, Brandt directly owns 517,604 shares of common stock and indirectly owns 105,290 shares through The Peter C. Brandt 2020-4 GRAT, for which he serves as trustee.
- He also directly owns 253,164 Series C warrants and 81,967 Series A warrants.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing simply reports transactions by a director, with no explicit positive or negative implications. The increased stake could be seen as a positive signal, but it's not definitive.
Positives
- Director's increased stake in the company may signal confidence in IN8BIO's future prospects.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors as they can provide insights into management's view of the company's prospects.
Stakeholder Impact
- Shareholders may view the director's increased stake as a positive sign.
Key Dates
| Date | Description |
|---|---|
| 12/13/2023 | Original grant date of Series A warrants with an exercise price of $1.25 and expiration date of June 13, 2025. |
| 06/13/2025 | Original expiration date of Series A warrants before amendment. |
| 10/04/2024 | Date of transaction: acquisition of shares and amendment of warrants. |
| 10/04/2025 | New expiration date of Series A warrants after amendment. |
| 10/04/2027 | Expiration date of Series C warrants. |
| 10/08/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.